Previous 10 | Next 10 |
FRAMINGHAM, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today announced the availability of Latitude Discovery , a new product aimed at pre-commercial biopharma and medical device compani...
FRAMINGHAM, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the Company is set to join the Russell 1000® Index at the conclusion of the q...
FRAMINGHAM, Mass., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder and Chief Executive Officer, Jason Krantz, and its Chief Financia...
When he was a medical device salesman, Motley Fool contributor Brian Feroldi needed to know where to go and who to talk to when he entered a hospital. Over a decade ago, that type of data was hard to come by. It could make the journey of a medical salesperson feel like running on a hamster ...
Definitive Healthcare (NASDAQ:DH) has closed a follow-on 11M-share offering. The offering was priced at $36 per share. The company did not say what the net proceeds from the offering are. Goldman Sachs and J.P. Morgan acted as joint book-runners. Definitive previously said net proceeds will b...
FRAMINGHAM, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced underwritten public offering of 11,000,000...
Definitive Healthcare (NASDAQ:DH) has priced its public offering of 11M shares of Class A common stock at $36.00/share. Underwriters' over-allotment is an additional 1.65M shares. Net proceeds will be used for acquisitions and general corporate purposes. Closing date is November 22, 2021. Sha...
FRAMINGHAM, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the pricing of an underwritten public offering of 11,000,000 shares of its Class A...
Shares of Definitive Healthcare (DH -13.1%) are down today following the company's public offering of 11M common shares. The company intends to use the proceeds for acquisitions and general corporate purposes, as well as share repurchases. Goldman Sachs and J.P. Morgan are acting as lead book...
Definitive Healthcare (NASDAQ:DH) announces the commencement of a public offering of 11M shares of its Class A common stock. Underwriters' over-allotment is an additional 1.65M shares. Net proceeds will be used for acquisitions and general corporate purposes and to repurchase up to 2,233,238 ...
News, Short Squeeze, Breakout and More Instantly...
Definitive Healthcare Corp. Company Name:
DH Stock Symbol:
NASDAQ Market:
Definitive Healthcare Corp. Website:
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Mon...
FRAMINGHAM, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of a redesigned mobile app for its popular View Suite platform. The new DH View Suite mobile app provides sales and marketing profess...
FRAMINGHAM, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced it has been named the 2024 Databricks Healthcare and Life Sciences Partner of the Year. This prestigious award recognizes Definitive H...